On the other hand, it has been recently showed that down regulation of PI3K-C2β may specifically confer resistance to leukemia cells to chemotherapy (thioguanine and mercaptopurine) (Diouf et al., 2011). This evidence concerns the gene PIK3CA and leukemia.